Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/13651| Title: | Pharmacotherapeutic approaches in the treatment of Alzheimer’s Disease |
| Authors: | Scerri, Charles |
| Keywords: | Alzheimer's disease -- Disease management Acetylcholinesterase Methyl aspartate |
| Issue Date: | 2006 |
| Publisher: | Malta College of Pharmacy Practice |
| Citation: | Scerri, C. (2006). Pharmacotherapeutic approaches in the treatment of Alzheimer’s Disease. Journal of the Malta College of Pharmacy Practice, 11, 8-10. |
| Abstract: | Alzheimer’s disease (AD) is the most common form of dementia and accounts for major cognitive impairment in the elderly. It is a progressive neurodegenerative disorder with distinct pathology. At present, the pharmacotherapy of AD involves the use of acetylcholinesterase inhibitors and the N-methyl-D-aspartate (NMDA) receptor antagonist memantine. The former imply neuroprotection hence slowing disease progression while the latter may block neuronal excitotoxicity. |
| URI: | https://www.um.edu.mt/library/oar//handle/123456789/13651 |
| Appears in Collections: | JMCPP, Issue 11 JMCPP, Issue 11 Scholarly Works - FacM&SPat |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 2006-11-2.pdf | Pharmacotherapeutic approaches in the treatment of Alzheimer’s Disease | 62.34 kB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.